Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats

Reductions in body weight following chronic central opioid receptor subtype antagonists during... Acute administration of long-acting general opioid antagonists reduces body weight and food intake in rats. In contrast, chronic administration of short-acting general opioid antagonists produces transient effects. The present study evaluated whether chronic central administration of selective long-acting antagonists of mu (beta-funaltrexamine, BFNA, 20 μg), mu 1 (naloxonazine, 50 μg), delta 1 (( d -Ala 2 ,Leu 5 ,Cys 6 )-enkephalin, DALCE, 50 μg), delta 2 (naltrindole isothiocyanate, NTII, 20 μg) or kappa (nor-binaltorphamine, NBNI, 20 μg) opioid receptor subtypes altered weight and intake of rats exposed to a palatable diet of pellets, fat, milk and water, relative to pellet-fed and diet-fed controls. Diet-fed rats receiving chronic vehicle injections significantly increased weight (7–10%) and intake over the 11-day time course. Weight was significantly reduced over the time course in rats administered either BFNA (9%), naloxonazine (12%), DALCE (7%) or NTII (6%). Initial weight reductions failed to persist following chronic NBNI. All antagonists chronically reduced fat intake, but did not systematically alter total intake, pellet intake or milk intake relative to the pattern of weight loss. These data indicate that central mu, mu 1 , delta 1 , delta 2 , and, to a lesser degree, kappa receptors mediate long-term opioid modulation of weight even in animals maintained on diets that ultimately result in dietary obesity. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Brain Research Elsevier

Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats

Loading next page...
 
/lp/elsevier/reductions-in-body-weight-following-chronic-central-opioid-receptor-1rMuW8YT00
Publisher
Elsevier
Copyright
Copyright © 1995 Elsevier Science B.V. All rights reserved
ISSN
0006-8993
DOI
10.1016/0006-8993(95)00181-O
Publisher site
See Article on Publisher Site

Abstract

Acute administration of long-acting general opioid antagonists reduces body weight and food intake in rats. In contrast, chronic administration of short-acting general opioid antagonists produces transient effects. The present study evaluated whether chronic central administration of selective long-acting antagonists of mu (beta-funaltrexamine, BFNA, 20 μg), mu 1 (naloxonazine, 50 μg), delta 1 (( d -Ala 2 ,Leu 5 ,Cys 6 )-enkephalin, DALCE, 50 μg), delta 2 (naltrindole isothiocyanate, NTII, 20 μg) or kappa (nor-binaltorphamine, NBNI, 20 μg) opioid receptor subtypes altered weight and intake of rats exposed to a palatable diet of pellets, fat, milk and water, relative to pellet-fed and diet-fed controls. Diet-fed rats receiving chronic vehicle injections significantly increased weight (7–10%) and intake over the 11-day time course. Weight was significantly reduced over the time course in rats administered either BFNA (9%), naloxonazine (12%), DALCE (7%) or NTII (6%). Initial weight reductions failed to persist following chronic NBNI. All antagonists chronically reduced fat intake, but did not systematically alter total intake, pellet intake or milk intake relative to the pattern of weight loss. These data indicate that central mu, mu 1 , delta 1 , delta 2 , and, to a lesser degree, kappa receptors mediate long-term opioid modulation of weight even in animals maintained on diets that ultimately result in dietary obesity.

Journal

Brain ResearchElsevier

Published: Apr 24, 1995

References

  • Modifications of nutrient selection by naloxone in rats
    Marks-Kaufman, R.; Kanarek, R.
  • Central and peripheral contributions of endogenous opioid systems to nutrient selection in rats
    Marks-Kaufman, R.; Plager, A.; Kanarek, R.
  • Effects of met-enkephalin and naloxone on gastric emptying and secretion in rhesus monkeys
    Shea-Donohue, T.; Adams, N.; Arnold, J.; Dubois, A.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off